FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors Meeting Abstract
| Authors: | Juneau, D.; Kavan, P.; Metser, U.; Abikhzer, G.; Bodei, L.; Liberman, M.; Taunk, N.; O'Reilly, E. M.; Ma, J. S.; Cioci, R.; Razak, A. R. A. |
| Abstract Title: | FRONTIER: FAPi Radioligand OpeN-label, phase 1 study to evaluate safety, Tolerability and dosImetry of [Lu-177]-PNT6555; a dose Escalation study for tReatment of patients with select solid tumors |
| Meeting Title: | 2024 SNMMI Annual Meeting |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 65 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Jun 8-11 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001289165600163 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 241162 -- Source: Wos |
